skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Alternative Chelator for 89 Zr Radiopharmaceuticals: Radiolabeling and Evaluation of 3,4,3-(LI-1,2-HOPO)

Journal Article · · Journal of Medicinal Chemistry
DOI:https://doi.org/10.1021/jm500389b· OSTI ID:1158701
 [1];  [2];  [3];  [4];  [4];  [3];  [5]
  1. Department of Radiology and the Program in Molecular Pharmacology and Chemistry, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, New York 10065, United States, Department of Chemistry, Hunter College of the City University of New York, 695 Park Avenue, New York, New York 10065, United States, Department of Chemistry, The Graduate School of the City University of New York, 365 Fifth Avenue, New York, New York 10016, United States
  2. Department of Radiology and the Program in Molecular Pharmacology and Chemistry, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, New York 10065, United States, Department of Chemistry, Hunter College of the City University of New York, 695 Park Avenue, New York, New York 10065, United States
  3. Department of Radiology and the Program in Molecular Pharmacology and Chemistry, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, New York 10065, United States
  4. Department of Chemistry, City University of New York—Hunter College and the Graduate School, 695 Park Avenue, New York, New York 10065, United States
  5. Department of Chemistry, Hunter College of the City University of New York, 695 Park Avenue, New York, New York 10065, United States, Department of Chemistry, The Graduate School of the City University of New York, 365 Fifth Avenue, New York, New York 10016, United States

Sponsoring Organization:
USDOE
Grant/Contract Number:
FG02-09ER16097; SC0001789
OSTI ID:
1158701
Journal Information:
Journal of Medicinal Chemistry, Journal Name: Journal of Medicinal Chemistry Vol. 57 Journal Issue: 11; ISSN 0022-2623
Publisher:
American Chemical SocietyCopyright Statement
Country of Publication:
United States
Language:
English
Citation Metrics:
Cited by: 121 works
Citation information provided by
Web of Science

References (50)

Calculating vibrational frequencies of amides: From formamide to concanavalin A journal January 2004
UFF, a full periodic table force field for molecular mechanics and molecular dynamics simulations journal December 1992
Solution Thermodynamic Stability of Complexes Formed with the Octadentate Hydroxypyridinonate Ligand 3,4,3-LI(1,2-HOPO): A Critical Feature for Efficient Chelation of Lanthanide(IV) and Actinide(IV) Ions journal July 2013
Revised effective ionic radii and systematic studies of interatomic distances in halides and chalcogenides journal September 1976
PET with the 89 Zr-Labeled Transforming Growth Factor-β Antibody Fresolimumab in Tumor Models journal November 2011
van der Waals Volumes and Radii journal March 1964
A Density Functional Theory Study of Vibrational Coupling in the Amide I Band of β-Sheet Models journal April 2008
89Zr Radiochemistry for Positron Emission Tomography journal September 2011
Preparation and evaluation of 89Zr-Zevalin for monitoring of 90Y-Zevalin biodistribution with positron emission tomography journal July 2006
A comparison of the behavior of functional/basis set combinations for hydrogen-bonding in the water dimer with emphasis on basis set superposition error journal February 2011
Development of Decorporation Agents for the Actinides journal October 1998
Chemical and biological properties of toxic metals and use of chelating agents for the pharmacological treatment of metal poisoning journal April 2010
Investigation of Zr( iv ) and 89 Zr( iv ) complexation with hydroxamates: progress towards designing a better chelator than desferrioxamine B for immuno-PET imaging journal January 2013
Imaging Androgen Receptor Signaling with a Radiotracer Targeting Free Prostate-Specific Antigen journal March 2012
Radiation Dosimetry of 89 Zr-Labeled Chimeric Monoclonal Antibody U36 as Used for Immuno-PET in Head and Neck Cancer Patients journal October 2009
Development and Characterization of Clinical-Grade 89 Zr-Trastuzumab for HER2/ neu ImmunoPET Imaging journal May 2009
How does basis set superposition error change the potential surfaces for hydrogen‐bonded dimers? journal December 1996
Chelation Therapies: A Chemical and Biochemical Perspective journal November 2010
Performance of Immuno–Positron Emission Tomography with Zirconium-89-Labeled Chimeric Monoclonal Antibody U36 in the Detection of Lymph Node Metastases in Head and Neck Cancer Patients journal April 2006
Underscoring the Influence of Inorganic Chemistry on Nuclear Imaging with Radiometals journal December 2013
A facile method for the labeling of proteins with zirconium isotopes journal May 1996
Evaluation of desferal as a bifunctional chelating agent for labeling antibodies with Zr-89
  • Meijs, Wilma E.; Herscheid, Jacobus D. M.; Haisma, Hidde J.
  • International Journal of Radiation Applications and Instrumentation. Part A. Applied Radiation and Isotopes, Vol. 43, Issue 12 https://doi.org/10.1016/0883-2889(92)90170-J
journal December 1992
Standardized methods for the production of high specific-activity zirconium-89 journal October 2009
89Zr-labeled compounds for PET imaging guided personalized therapy journal June 2011
Synthesis and Initial Evaluation for In Vivo Chelation of Pu(IV) of a Mixed Octadentate Spermine-Based Ligand Containing 4-Carbamoyl-3-hydroxy-1-methyl-2(1 H )-pyridinone and 6-Carbamoyl-1-hydroxy-2(1 H )-pyridinone journal August 2002
p-Isothiocyanatobenzyl-desferrioxamine: a new bifunctional chelate for facile radiolabeling of monoclonal antibodies with zirconium-89 for immuno-PET imaging journal September 2009
In vivo biodistribution and accumulation of 89Zr in mice journal July 2011
Infrared Spectroscopic Studies of Siderophore-Related Hydroxamic Acid Ligands Adsorbed on Titanium Dioxide journal November 2006
89Zr-trastuzumab PET visualises HER2 downregulation by the HSP90 inhibitor NVP-AUY922 in a human tumour xenograft journal February 2010
Quantitative PET imaging of Met-expressing human cancer xenografts with 89Zr-labelled monoclonal antibody DN30 journal May 2008
PET Tracers Based on Zirconium-89 journal April 2011
The rise of metal radionuclides in medical imaging: copper-64, zirconium-89 and yttrium-86 journal April 2011
Rational Design of Sequestering Agents for Plutonium and Other Actinides journal November 2003
Biodistribution of 89Zr-trastuzumab and PET Imaging of HER2-Positive Lesions in Patients With Metastatic Breast Cancer journal March 2010
Multidentate hydroxypyridinonate ligands for Pu(IV) chelation in vivo : comparative efficacy and toxicity in mouse of ligands containing 1,2-HOPO or Me-3,2-HOPO journal January 2000
Matching chelators to radiometals for radiopharmaceuticals journal January 2014
The Next Generation of Positron Emission Tomography Radiopharmaceuticals in Oncology journal July 2011
Stereochemistry of Discrete Eight-Coördination. III. Tetrasodium Tetrakisoxalatozirconate(IV) Trihydrate journal April 1963
Quantum Calculation of Molecular Energies and Energy Gradients in Solution by a Conductor Solvent Model journal March 1998
Stereochemistry of Discrete Eight-Coördination. I. Basic Analysis journal April 1963
PET imaging with 89Zr: From radiochemistry to the clinic journal January 2013
PET and MRI of Metastatic Peritoneal and Pulmonary Colorectal Cancer in Mice with Human Epidermal Growth Factor Receptor 1–Targeted 89 Zr-Labeled Panitumumab journal January 2012
Applying PET to Broaden the Diagnostic Utility of the Clinically Validated CA19.9 Serum Biomarker for Oncology journal September 2013
Synthesis of 3,4,3 LI 1,2 HOPO labelled with 14C: Synthesis of 3,4,3 journal February 2001
Hydrogen Bonding in Biological Structures book January 1991
A practical guide to the construction of radiometallated bioconjugates for positron emission tomography journal January 2011
Comparative Toxicity of 3,4,3-LIHOPO and DTPA in Baboons: Preliminary Results journal May 1994
Energies, structures, and electronic properties of molecules in solution with the C-PCM solvation model journal April 2003
89Zr-DFO-J591 for ImmunoPET of Prostate-Specific Membrane Antigen Expression In Vivo journal July 2010
89 Zr-Bevacizumab PET of Early Antiangiogenic Tumor Response to Treatment with HSP90 Inhibitor NVP-AUY922 journal April 2010

Similar Records

Related Subjects